The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria Andrea LaneseEnrico FranceschiAlba A. Brandes Commentary Open access 16 July 2018 Pages: 105 - 108
The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice Adi LitmanovichKhaled KhazimIdan Cohen Review Open access 28 November 2018 Pages: 109 - 127
Mastocytosis: One Word for Different Diseases Marianna CriscuoloLuana FianchiLivio Pagano Review Open access 29 October 2018 Pages: 129 - 140
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation Simon J. JohnstonKwok-Leung Cheung Review Open access 10 July 2018 Pages: 141 - 156
Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases Shunji TakahashiSeigo KinuyaYoshiyuki Kakehi Original Research Open access 11 December 2018 Pages: 157 - 171
Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient–Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study Philip CornfordKieran JeffersonJohn Gilbody Original Research Open access 05 November 2018 Pages: 173 - 187
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Tian Qi WangJoseph N. SamuelDoris Howell Original Research Open access 22 October 2018 Pages: 189 - 201
Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan Takashi SetoNaoyuki NogamiHideo Saka Original Research Open access 28 August 2018 Pages: 203 - 215
